Biotech and Pharma Stocks

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.

BIOTECH & PHARMA

Incannex receives ethics approval for novel cannabinoid in phase 2b obstructive sleep apnoea trial

PharmAust advances testing of monepantel drugs against COVID-19

PharmAust receives grant from FightMND for monepantel phase one trial in motor neuron disease

Immutep announces improved results in two parallel clinical trials into lead drug eftilagimod alpha

Osteopore looks to expand its range of 3D-printed bioresorbable implants

PharmAust lays out market strategy for lead drug monepantel

PharmAust confirms monepantel’s anti-viral potential in fight against COVID-19

Biotron ruffles through its compound database in search of COVID-19 drug

Opyl unveils AI platform capable of forecasting COVID-19 clinical trial success

PharmAust trims losses as monepantel drug development progresses

Prescient Therapeutics raises $7 million to fund cancer treatment pipeline

Incannex announces in vitro results from sepsis-associated acute respiratory disease drug studies

PharmAust research shows monepantel can inhibit progression of SARS-CoV-2 virus

Investors back Osteopore’s expansion plans in $8.5m placement

Kazia Therapeutics’ paxalisib drug granted fast track designation for treatment of glioblastoma

GreenStar Biosciences set for psychedelic market leap via acquisition of Eleusian

Mesoblast’s lead drug candidate achieves major regulatory milestone after US FDA vote

Prescient Therapeutics teams up with Peter MacCallum Cancer Centre to advance CAR-T cancer therapy

Regeneus signs agreement with Kyocera for licensing of Progenza knee osteoarthritis drug to Japanese market

Emerald Clinics signs cannabis RWE contract with Canopy Growth’s UK subsidiary Spectrum Biomedical

Atomo Diagnostics receives TGA approval to supply COVID-19 antibody test kit to Australian market